A plain-English look at SRx Health Solutions' revenue, losses, and market value since its April 2025 IPO on the NYSE.
Every public company tells two stories at once: what it does, and what the numbers say about how that business is going. For SRx Health Solutions, Inc., those two stories are worth separating carefully, because the figures paint a picture of a very small, very new public company still finding its footing.
What SRx Health Solutions Does
According to its company description, SRx Health Solutions operates the continuing pet health and wellness business under the Halo brand. It makes premium and super-premium foods, treats, toppers, chews, dental products, and supplements for dogs and cats, formulated to specific sourcing and nutritional standards and made through co-manufacturing partnerships rather than in-house factories.
A Legacy Pet Food Business
The company's Consumer Products segment includes the legacy Halo pet food line, spanning dry kibble, wet food, freeze-dried raw food, treats, and toppers. Products reach customers primarily through e-commerce platforms rather than traditional brick-and-mortar retail.
Where the Company Is Based and How Big It Is
SRx Health Solutions is headquartered in North Palm Beach, Florida, and runs with a lean team of approximately 11 employees. That is a notably small workforce for a company trading on a major exchange, underscoring just how early-stage this business is in its public life.
A Fresh Arrival on the NYSE
The company completed its initial public offering in April 2025, making it one of the more recently listed names on the New York Stock Exchange under the ticker SRXH. New listings often come with volatility as the market works out how to value them, and SRx Health Solutions' trading history so far reflects that.
Revenue at a Small Scale
For fiscal year 2025, SRx Health Solutions reported revenue of $6.5 million. That is a modest top line for a publicly traded company, placing it firmly in the small-cap category rather than among larger, more established consumer brands.
Profitability: A Significant Net Loss
The company reported a net loss of $45.0 million in FY2025. That loss figure is roughly seven times larger than the company's entire annual revenue, which is a meaningful gap between money coming in and the company's overall financial result for the year.
Assets on the Balance Sheet
Total assets stood at $8.4 million. Comparing that figure to the reported net loss shows the scale of the challenge: the loss for the year was larger than the total assets the company currently holds.
Market Value Versus the Balance Sheet
Despite the small revenue base and the sizable net loss, SRx Health Solutions carries a market capitalization of $71.3 million. That valuation is considerably higher than the company's $8.4 million in total assets, a gap that can happen with newly public companies where investors are pricing in expectations about the future rather than current balance-sheet size alone.
A Steep Drop From Its High
The recent share price was listed at $2.74, delayed by fifteen minutes from real-time trading. That price puts the stock 93% below its 52-week high, a substantial decline that reflects how much the market's view of the company has shifted since its highest trading point over the past year.
Putting the Numbers Together
Taken together, the picture is one of a very young public company: a small pet-wellness business with modest revenue, a large net loss relative to its size, thin total assets, and a stock price that has fallen sharply from its post-IPO peak. None of these figures predict what comes next; they simply describe where the company stands today.
This article is factual reporting based on publicly available filings and market data, and it is not investment advice.